Skip to main content

Day: May 2, 2022

Artificial Lift System Market Size [2022-2026] To Reach USD 13 Billion at a CAGR of 5.32% | Industry Trends, Share, And Growth Analysis

According to Fortune Business Insights, Artificial Lift System Market size is projected to grow from USD 8.4 billion in 2018 to USD 13 billion in 2026, at CAGR of 5.32% during 2022 to 2026; Demand for Hydrocarbon to Propel Market Growth, says Fortune Business Insights. Pune, India, May 02, 2022 (GLOBE NEWSWIRE) — The global artificial lift system market is projected to reach USD 13 Billion by the end of 2026. Fortune Business Insights has predicted that the market will rise from its 2018 valuation of USD 8.4 billion at a CAGR of 5.32%. Artificial list system provides production capability that in turn, reduces the cost of operation. It also provides long lasting well life. These two major factors will contribute to market growth. The ever grossing demand for hydrocarbon will help the global artificial lift system market to grow...

Continue reading

uniQure Announces First Quarter 2022 Financial Results and Highlights Recent Company Progress

~ Partner CSL Behring submitted Marketing Authorization Application (MAA) in Europe foretranacogene dezaparvovec in hemophilia B; MAA validated by the European Medicines Agency (EMA)and granted accelerated assessment ~ ~ Received $55 million in milestone payments associated with global submissions of marketing and license applications ~ ~ Completed patient enrollment of higher dose cohort of U.S. Phase I/II study of AMT-130 and lower dose cohort of European Phase Ib/II study; total of 32 patient procedures completed to date ~ ~ One year safety and biomarker data from all 10 patients in lower dose cohort of U.S. Phase I/II study of AMT-130 in Huntington’s disease, including mHTT and NfL biomarkers, expected in second quarter 2022 ~ ~ Multiple preclinical data presentations to be featured at American Society of Gene and Cell Therapy (ASGCT)...

Continue reading

Centrifugal Pump Market Size to Hit USD 45.56 Billion by 2028 | Industry Share, Growth and Trends Forecast Analysis

According to Fortune Business Insights, the global centrifugal pump market size is projected to grow from USD 30.56 billion in 2021 to USD 45.56 billion in 2028, at CAGR of 5.9% during forecast period; Rising commercial and residential spaces construction to boost market development.Centrifugal Pump Market Share Centrifugal Pump Market SharePune, India, May 02, 2022 (GLOBE NEWSWIRE) — The global centrifugal pump market size is projected to reach USD 45.56 billion by 2028, exhibiting a CAGR of 5.9% during the forecast period. The market was valued at USD 29.24 billion in 2020 and is estimated to reach USD 30.56 billion in 2021. Rising commercial and residential infrastructure developments and extensive pump adoption in several applications are expected to boost market development. Fortune Business Insights™ mentions this information...

Continue reading

Nova LifeStyle Inc. to Debut 30th Anniversary Collection at Summer Edition of Las Vegas Market

In Celebration of 30 years in the Home Furnishings Industry, Diamond Sofa readies its Single Largest Collection Launch in its History Increases International PresenceLOS ANGELES, May 02, 2022 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) is pleased to announce, Diamond Sofa, a wholly owned subsidiary of the Company, is scheduled to launch its single largest collection at the 2022 Summer Edition of Las Vegas Market, July 24 to 28, 2022. Las Vegas Market is the leading home furnishings and gift market in the western U.S., presenting thousands of furniture, home décor and gift resources in an unrivaled market destination. Its diverse product offerings allow for cross category commerce among these industries. Tawny Lam, Chairperson and Chief Executive Officer of Nova LifeStyle stated,...

Continue reading

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

— Herbert Y. Meltzer, MD; Karl Deisseroth, MD, PhD; Robert C. Malenka, MD, PhD; Michael P. Bogenschutz, MD; and Peter Hendricks, PhD, bring decades of clinical and research expertise in psychiatry, addiction, behavioral health, and pharmacology to guide Company’s development programs — –Scientific Advisory Board members are affiliated with cutting-edge programs at elite academic and medical institutions — — Jan Torleif Pedersen, PhD, MSc, CNS drug specialist, to join Board of Directors — VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) —  Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced the...

Continue reading

Teleflex to Host Analyst & Investor Day on May 20, 2022

WAYNE, Pa., May 02, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced that the Company will host an Analyst & Investor Day on Friday, May 20, 2022 in New York City. Liam Kelly, Chairman, President and CEO, will be joined by members of the Company’s Leadership Team and Expert Panelists. A live webcast of the event presentations will begin at 10:00 a.m. ET. 2022 Analyst & Investor Day Agenda Overview: 9:00 a.m. Registration and Breakfast 10:00 a.m. PresentationsSection 1:A Foundation for Durable GrowthSection 2:Deep Dive into Select Growth DriversSection 3:Financial Objectives: 2023 – 20251:30 p.m. Presentations and Webcast Conclude. Live Attendee Breakout Sessions with the Leadership Team. 2:30 p.m. Event Concludes A live webcast of the presentations...

Continue reading

Healthcare Realty Trust and Healthcare Trust of America Provide Update on Strategic Combination

NASHVILLE, Tenn. and SCOTTSDALE, Ariz., May 02, 2022 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or “HR”) and Healthcare Trust of America, Inc. (NYSE: HTA) (“HTA”) today provided an update on their previously announced $18 billion strategic combination, creating the preeminent medical office building REIT. Healthcare Realty and HTA have received letters of intent from, and are in advanced negotiations with, three institutional investors for a combination of joint ventures and asset sales totaling $1.7 billion at a weighted average cap rate of approximately 4.8%. Net proceeds from these transactions would be approximately $1.6 billion. The transactions may occur in separate tranches, with the initial transactions targeted to close prior to the vote on the merger by HR and HTA...

Continue reading

Park Hotels & Resorts Inc. Reports First Quarter 2022 Results

TYSONS, Va., May 02, 2022 (GLOBE NEWSWIRE) — Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE: PK) today announced results for the first quarter ended March 31, 2022 and provided an operational update. First quarter financial highlights include:RevPAR was $116.42, an increase of $75.10, or 181.7%, on a pro-forma basis from the same period in 2021 and a decrease of 32.8% on a pro-forma basis from the same period in 2019; Occupancy for Park’s 46 consolidated hotels open during the first quarter was 54.4%; Net loss and net loss attributable to stockholders were $(56) million and $(57) million, respectively, which represent an improvement of 70.7% and 70.0%, respectively, compared to the same period in 2021; Adjusted EBITDA was $82 million, an increase of 1.8%, compared to the fourth quarter of 2021; Hotel Adjusted...

Continue reading

Turnover of Apranga Group in April 2022

Retail turnover (including VAT) of Apranga Group amounted to EUR 22.6 million in April 2022 and increased by 81.3% comparing to April 2021. Due to epidemic coronavirus (COVID-19) infection, from 16 December 2020, all the Group’s stores in Lithuania were temporarily closed (stores with a separate entrance from the outside and sales area not exceeding 300 square meters were open from 15 February 2021, stores with a separate entrance from the outside and a sales area exceeding 300 square meters were open from 15 March 2021). All Group’s stores have been reopened in Lithuania from 19 April 2021, however, stores operating in shopping malls were not allowed to work on weekends, unless they had separate entrance from outside. In Latvia, stores were temporarily closed from 19 December 2020, and in Estonia – from 11 March 2021. These temporary...

Continue reading

SEB Reports Q1/2022 Results

8 Consecutive Quarters of Positive Adjusted EBITDA;Conference Call Tuesday May 3 at 4:00 P.M.Q1/2022 revenue increased by 11.7% vs Q1/2021, with revenues at $16.0 million Posted 8th consecutive quarter of positive adjusted EBITDA Trailing Twelve Months (“TTM”) revenue increased by $5.0 million (8.6%) and TTM gross profit increased by $1.4 million (6.6%) Over 90% of targeted 2022 revenues are currently under contract Future revenue and EBITDA are expected to experience significant growth, driven by the Company’s strong business pipelineCONFERENCE CALL DETAILS:Management will host a call:Date/Time: Tuesday May 3, at 4:00 PM ETCanada & USA Toll Free Dial In: 1-800-319-4610Toronto Toll Dial In: 1-416-915-3239Callers should dial in 5-10 minutes prior to the scheduled start time and simply ask to join the call. Webcast Link access at...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.